Eikon Therapeutics, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| – | – | – | |
| – | – | – | |
| – | – | – | |
| – | -1.3% | +22.4% | |
| – | -4.6% | +58.8% | |
| – | -2.0% | +20.9% | |
| – | – | – | |
| – | -20.5% | +2,600.0% | |
| – | – | – | |
| – | – | – | |
| – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.